Evidence map›Paper›PMID 34367467›Full record

ArticleOxidative medicine and cellular longevity2021

Inhibition of Fatty Acid Metabolism Increases EPA and DHA Levels and Protects against Myocardial Ischaemia-Reperfusion Injury in Zucker Rats.

Janis Kuka, Marina Makrecka-Kuka, Karlis Vilks, Stanislava Korzh, Helena Cirule, Eduards Sevostjanovs, Solveiga Grinberga, Maija Dambrova, Edgars Liepinsh

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Janis KukaLatvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.ORCID https://orcid.org/0000-0002-0411-0229
Marina Makrecka-KukaLatvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.
Karlis VilksLatvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.
Stanislava KorzhLatvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.
Helena CiruleLatvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.
Eduards SevostjanovsLatvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.
Solveiga GrinbergaLatvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.ORCID https://orcid.org/0000-0002-7009-4220
Maija DambrovaLatvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.ORCID https://orcid.org/0000-0002-1739-0928
Edgars LiepinshLatvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Riga, Latvia.
Latvijas Organiskās Sintēzes Institūts · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-chain

Indexed as

Insulin ResistanceAnimalsDocosahexaenoic AcidsEicosapentaenoic Acidgamma-Aminobutyric AcidLipid MetabolismMaleMetabolomeMyocardial Reperfusion InjuryQuaternary Ammonium CompoundsRatsRats, ZuckerDocosahexaenoic AcidsEicosapentaenoic Acidgamma-Aminobutyric Acidmethyl-gamma-butyrobetaineQuaternary Ammonium Compounds

Identifiers

PMID34367467
PMCPMC8342141
OpenAlexW3184262122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.